Nicole Curci
Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Neoplasms | 12 | 2022 | 333 | 2.800 |
Why?
| Carcinoma, Renal Cell | 7 | 2022 | 174 | 2.080 |
Why?
| Prostatic Neoplasms | 8 | 2023 | 939 | 1.450 |
Why?
| Magnetic Resonance Imaging | 11 | 2023 | 3169 | 1.070 |
Why?
| Femoral Vein | 2 | 2012 | 29 | 0.850 |
Why?
| Aneurysm | 2 | 2012 | 32 | 0.840 |
Why?
| Catheter Ablation | 2 | 2022 | 286 | 0.780 |
Why?
| Venous Thrombosis | 2 | 2012 | 145 | 0.740 |
Why?
| Embolization, Therapeutic | 2 | 2012 | 192 | 0.730 |
Why?
| Prostate | 4 | 2018 | 158 | 0.700 |
Why?
| Watchful Waiting | 1 | 2018 | 55 | 0.630 |
Why?
| Tomography, X-Ray Computed | 10 | 2022 | 2433 | 0.620 |
Why?
| Kidney Diseases, Cystic | 3 | 2021 | 20 | 0.600 |
Why?
| Pulmonary Artery | 2 | 2012 | 1055 | 0.550 |
Why?
| Quality Assurance, Health Care | 1 | 2018 | 324 | 0.550 |
Why?
| Radiology | 4 | 2021 | 199 | 0.540 |
Why?
| Bezoars | 1 | 2011 | 4 | 0.410 |
Why?
| Intussusception | 1 | 2011 | 27 | 0.410 |
Why?
| Immunosuppressive Agents | 2 | 2012 | 682 | 0.390 |
Why?
| Pneumonectomy | 1 | 2012 | 115 | 0.390 |
Why?
| Intestine, Small | 1 | 2011 | 130 | 0.370 |
Why?
| Radiology Information Systems | 2 | 2018 | 31 | 0.320 |
Why?
| Ultrasonography | 3 | 2023 | 714 | 0.310 |
Why?
| Biopsy | 4 | 2023 | 1078 | 0.300 |
Why?
| Ovarian Neoplasms | 2 | 2023 | 420 | 0.290 |
Why?
| Retrospective Studies | 13 | 2023 | 12929 | 0.270 |
Why?
| Teaching | 2 | 2018 | 235 | 0.270 |
Why?
| Microwaves | 2 | 2022 | 36 | 0.240 |
Why?
| Humans | 30 | 2023 | 118251 | 0.230 |
Why?
| Magnetic Resonance Imaging, Interventional | 1 | 2023 | 20 | 0.230 |
Why?
| Ovarian Diseases | 1 | 2023 | 12 | 0.230 |
Why?
| Kidney | 6 | 2021 | 1351 | 0.220 |
Why?
| Aged | 8 | 2022 | 19594 | 0.220 |
Why?
| Cysts | 1 | 2023 | 93 | 0.210 |
Why?
| Peritoneal Neoplasms | 1 | 2022 | 52 | 0.210 |
Why?
| Prostatectomy | 2 | 2022 | 99 | 0.210 |
Why?
| Angiography | 2 | 2012 | 185 | 0.200 |
Why?
| Syndrome | 2 | 2012 | 343 | 0.200 |
Why?
| Salpingo-oophorectomy | 1 | 2020 | 12 | 0.190 |
Why?
| Contrast Media | 2 | 2021 | 373 | 0.190 |
Why?
| Neoplasm Grading | 2 | 2018 | 257 | 0.190 |
Why?
| Robotic Surgical Procedures | 1 | 2022 | 89 | 0.190 |
Why?
| Diagnosis, Differential | 3 | 2021 | 1379 | 0.190 |
Why?
| Pelvic Neoplasms | 1 | 2020 | 20 | 0.180 |
Why?
| Incidental Findings | 1 | 2020 | 80 | 0.180 |
Why?
| Biliary Tract Neoplasms | 1 | 2020 | 20 | 0.180 |
Why?
| Interdisciplinary Placement | 1 | 2019 | 2 | 0.180 |
Why?
| Multidetector Computed Tomography | 1 | 2019 | 27 | 0.180 |
Why?
| Middle Aged | 10 | 2022 | 27510 | 0.170 |
Why?
| Teacher Training | 1 | 2018 | 6 | 0.160 |
Why?
| Radiography, Abdominal | 1 | 2018 | 32 | 0.160 |
Why?
| Adrenal Gland Neoplasms | 1 | 2019 | 81 | 0.160 |
Why?
| Mentoring | 1 | 2019 | 101 | 0.150 |
Why?
| Treatment Outcome | 4 | 2022 | 9319 | 0.150 |
Why?
| Glomerular Filtration Rate | 1 | 2021 | 681 | 0.150 |
Why?
| Education, Medical, Continuing | 1 | 2018 | 124 | 0.150 |
Why?
| Machine Learning | 1 | 2019 | 321 | 0.140 |
Why?
| Sequence Analysis, RNA | 1 | 2018 | 410 | 0.140 |
Why?
| Male | 13 | 2023 | 57474 | 0.140 |
Why?
| Risk Assessment | 2 | 2018 | 3043 | 0.140 |
Why?
| Radiography | 1 | 2018 | 860 | 0.130 |
Why?
| Delivery of Health Care, Integrated | 1 | 2018 | 230 | 0.130 |
Why?
| Education, Medical | 1 | 2018 | 239 | 0.130 |
Why?
| Adipose Tissue | 1 | 2019 | 595 | 0.130 |
Why?
| Reproducibility of Results | 2 | 2018 | 2855 | 0.120 |
Why?
| Follow-Up Studies | 2 | 2012 | 4574 | 0.110 |
Why?
| Predictive Value of Tests | 1 | 2018 | 1857 | 0.110 |
Why?
| Transcriptome | 1 | 2018 | 752 | 0.110 |
Why?
| Prunus | 1 | 2011 | 2 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1787 | 0.100 |
Why?
| Female | 10 | 2023 | 61261 | 0.100 |
Why?
| Abdomen, Acute | 1 | 2011 | 19 | 0.100 |
Why?
| Vena Cava Filters | 1 | 2012 | 50 | 0.100 |
Why?
| Internship and Residency | 2 | 2018 | 1005 | 0.100 |
Why?
| Longitudinal Studies | 1 | 2018 | 2491 | 0.100 |
Why?
| Rare Diseases | 1 | 2012 | 93 | 0.100 |
Why?
| Prednisone | 1 | 2012 | 235 | 0.100 |
Why?
| Prospective Studies | 2 | 2023 | 6443 | 0.100 |
Why?
| Vascular Surgical Procedures | 1 | 2012 | 262 | 0.090 |
Why?
| Combined Modality Therapy | 1 | 2012 | 1163 | 0.080 |
Why?
| Adult | 5 | 2020 | 31324 | 0.080 |
Why?
| Glucocorticoids | 1 | 2012 | 545 | 0.080 |
Why?
| Laparoscopy | 1 | 2011 | 417 | 0.070 |
Why?
| Societies, Medical | 2 | 2019 | 701 | 0.060 |
Why?
| Severity of Illness Index | 1 | 2012 | 2659 | 0.060 |
Why?
| Torsion Abnormality | 1 | 2023 | 18 | 0.060 |
Why?
| Image-Guided Biopsy | 1 | 2023 | 34 | 0.060 |
Why?
| Urologists | 1 | 2023 | 18 | 0.060 |
Why?
| Gallium Isotopes | 1 | 2022 | 1 | 0.050 |
Why?
| Gallium Radioisotopes | 1 | 2022 | 19 | 0.050 |
Why?
| Neoplasm, Residual | 1 | 2022 | 103 | 0.050 |
Why?
| Algorithms | 2 | 2019 | 1522 | 0.050 |
Why?
| Radiologists | 1 | 2021 | 38 | 0.050 |
Why?
| Portal Vein | 1 | 2020 | 90 | 0.040 |
Why?
| Peer Review | 1 | 2019 | 40 | 0.040 |
Why?
| Angiomyolipoma | 1 | 2019 | 18 | 0.040 |
Why?
| Cohort Studies | 2 | 2020 | 5078 | 0.040 |
Why?
| Pelvis | 1 | 2020 | 92 | 0.040 |
Why?
| Digital Rectal Examination | 1 | 2018 | 10 | 0.040 |
Why?
| Organizational Objectives | 1 | 2018 | 74 | 0.040 |
Why?
| Faculty | 1 | 2019 | 135 | 0.040 |
Why?
| Artifacts | 1 | 2019 | 125 | 0.040 |
Why?
| Peer Group | 1 | 2019 | 206 | 0.040 |
Why?
| Delphi Technique | 1 | 2018 | 163 | 0.040 |
Why?
| Education, Distance | 1 | 2018 | 36 | 0.040 |
Why?
| Molecular Diagnostic Techniques | 1 | 2018 | 95 | 0.040 |
Why?
| Carbon | 1 | 2019 | 169 | 0.040 |
Why?
| Terminology as Topic | 1 | 2019 | 199 | 0.040 |
Why?
| Problem-Based Learning | 1 | 2018 | 82 | 0.040 |
Why?
| Prostate-Specific Antigen | 1 | 2018 | 155 | 0.040 |
Why?
| Adipocytes | 1 | 2019 | 195 | 0.040 |
Why?
| Needs Assessment | 1 | 2019 | 325 | 0.040 |
Why?
| Evidence-Based Practice | 1 | 2018 | 193 | 0.040 |
Why?
| Referral and Consultation | 1 | 2021 | 644 | 0.040 |
Why?
| Consensus | 1 | 2018 | 533 | 0.030 |
Why?
| Clinical Decision-Making | 1 | 2018 | 277 | 0.030 |
Why?
| Case-Control Studies | 1 | 2023 | 3156 | 0.030 |
Why?
| Research Design | 1 | 2021 | 961 | 0.030 |
Why?
| Learning | 1 | 2018 | 373 | 0.030 |
Why?
| Genomics | 1 | 2018 | 668 | 0.030 |
Why?
| Gene Expression | 1 | 2018 | 1482 | 0.030 |
Why?
| Genetic Predisposition to Disease | 1 | 2020 | 2262 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2022 | 4521 | 0.030 |
Why?
| Prognosis | 1 | 2018 | 3424 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2021 | 6541 | 0.020 |
Why?
| Child, Preschool | 1 | 2023 | 9448 | 0.020 |
Why?
| Child | 1 | 2023 | 19033 | 0.010 |
Why?
|
|
Curci's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|